Emerging bacterial, fungal, and viral respiratory infections in transplantation

Infectious Disease Clinics of North America

Volumn 24, Issue 3, 2010, Pages 541-555

  Nishi, Shawn P E ^a   Valentine, Vincent G ^a   Duncan, Steve ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Emerging; Respiratory infections; Transplant

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPHOTERICIN B; CARBAPENEM; CASPOFUNGIN; CEFOXITIN; CEPHALOSPORIN; CLARITHROMYCIN; COTRIMOXAZOLE; ECHINOCANDIN; IMIPENEM; IMMUNOGLOBULIN; ITRACONAZOLE; LINEZOLID; MINOCYCLINE; MOXIFLOXACIN; POSACONAZOLE; PREDNISOLONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN; SULFONAMIDE; TERBINAFINE; TETRACYCLINE; VANCOMYCIN; VORICONAZOLE;

ASPERGILLUS NIDULANS; ASPERGILLUS USTUS; BACTERIAL INFECTION; FUSARIOSIS; FUSARIUM SOLANI; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG INFECTION; LUNG MYCOSIS; LUNG TRANSPLANTATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; METAPNEUMOVIRUS; METAPNEUMOVIRUS INFECTION; MORBIDITY; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; NOCARDIA; NOCARDIOSIS; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PERIOPERATIVE PERIOD; PNEUMOCYSTIS PNEUMONIA; PSEUDALLESCHERIASIS; RESPIRATORY TRACT INFECTION; REVIEW; RHODOCOCCUS EQUI; SCEDOSPORIUM; SCEDOSPORIUM APIOSPERMUM; SCEDOSPORIUM PROLIFICANS; SEVERE ACUTE RESPIRATORY SYNDROME; SURGICAL TECHNIQUE; SURVIVAL TIME; VIRAL RESPIRATORY TRACT INFECTION; BACTERIAL INFECTIONS; IMMUNOCOMPROMISED PATIENT; MICROBIOLOGY; MYCOSES; RESPIRATORY TRACT INFECTIONS; TRANSPLANTATION; VIROLOGY; VIRUS DISEASES;

BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; RESPIRATORY TRACT INFECTIONS; TRANSPLANTATION; VIRUS DISEASES;

EID: 77955250349     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2010.04.005     Document Type: Review

References (106)

1. Kumar D., Humar A. Emerging viral infections in transplant recipients. Curr Opin Infect Dis 2005, 18(4):337-341.
2. Roberts S.A., Franklin J.C., Mijch A., et al. Nocardia infection in heart-lung transplant recipients at Alfred Hospital, Melbourne, Australia, 1989-1998. Clin Infect Dis 2000, 31(4):968-972.
3. Husain S., McCurry K., Dauber J., et al. Nocardia infection in lung transplant recipients. J Heart Lung Transplant 2002, 21(3):354-359.
4. Wiesmayr S., Stelzmueller I., Tabarelli W., et al. Nocardiosis following solid organ transplantation: a single-centre experience. Transpl Int 2005, 18(9):1048-1053.
5. Peraira J.R., Segovia J., Fuentes R., et al. Pulmonary nocardiosis in heart transplant recipients: treatment and outcome. Transplant Proc 2003, 35(5):2006-2008.
6. Poonyagariyagorn H.K., Gershman A., Avery R., et al. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients. Transpl Infect Dis 2008, 10(6):403-408.
7. Peleg A.Y., Husain S., Qureshi Z.A., et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis 2007, 44(10):1307-1314.
8. Brown-Elliott B.A., Brown J.M., Conville P.S., et al. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 2006, 19(2):259-282.
9. Wallace R.J., Brown B.A., Brown J.M., et al. Taxonomy of Nocardia species. Clin Infect Dis 1994, 18(3):476-477.
10. Khan B.A., Duncan M., Reynolds J., et al. Nocardia infection in lung transplant recipients. Clin Transplant 2008, 22(5):562-566.
11. Oszoyoglu A.A., Kirsch J., Mohammed T.L. Pulmonary nocardiosis after lung transplantation: CT findings in 7 patients and review of the literature. J Thorac Imaging 2007, 22(2):143-148.
12. Simpson G.L., Stinson E.B., Egger M.J., et al. Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis 1981, 3(3):492-507.
13. Montoya J.G., Giraldo L.F., Efron B., et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis 2001, 33(5):629-640.
14. Lopez F.A., Johnson F., Novosad D.M., et al. Successful management of disseminated Nocardia transvalensis infection in a heart transplant recipient after development of sulfonamide resistance: case report and review. J Heart Lung Transplant 2003, 22(4):492-497.
15. McNeil M.M., Brown J.M., Magruder C.H., et al. Disseminated Nocardia transvalensis infection: an unusual opportunistic pathogen in severely immunocompromised patients. J Infect Dis 1992, 165(1):175-178.
16. McNeil M.M., Brown J.M., Georghiou P.R., et al. Infections due to Nocardia transvalensis: clinical spectrum and antimicrobial therapy. Clin Infect Dis 1992, 15(3):453-463.
17. Weinberger M., Eid A., Schreiber L., et al. Disseminated Nocardia transvalensis infection resembling pulmonary infarction in a liver transplant recipient. Eur J Clin Microbiol Infect Dis 1995, 14(4):337-341.
18. Threlkeld S.C., Hooper D.C. Update on management of patients with Nocardia infection. Curr Clin Top Infect Dis 1997, 17:1-23.
19. Ezaki T. Kekkaku 1992, 67(12):803-808. [in Japanese].
20. Olivier K.N., Weber D.J., Wallace R.J., et al. Nontuberculous mycobacteria. I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003, 167(6):828-834.
21. Chernenko S.M., Humar A., Hutcheon M., et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant 2006, 25(12):1447-1455.
22. Fairhurst R.M., Kubak B.M., Shpiner R.B., et al. Mycobacterium abscessus empyema in a lung transplant recipient. J Heart Lung Transplant 2002, 21(3):391-394.
23. Sanguinetti M., Ardito F., Fiscarelli E., et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 2001, 39(2):816-819.
24. Chalermskulrat W., Sood N., Neuringer I.P., et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006, 61(6):507-513.
25. Zaidi S., Elidemir O., Heinle J.S., et al. Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence. Transpl Infect Dis 2009, 11(3):243-248.
26. Taylor J.L., Palmer S.M. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant 2006, 25(8):985-988.
27. Morales P., Ros J.A., Blanes M., et al. Successful recovery after disseminated infection due to Mycobacterium abscessus in a lung transplant patient: subcutaneous nodule as first manifestation-a case report. Transplant Proc 2007, 39(7):2413-2415.
28. Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS 2006, 114(5):319-328.
29. Wallace R.J. Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis 1994, 13(11):953-960.
30. Weinstock D.M., Brown A.E. Rhodococcus equi: an emerging pathogen. Clin Infect Dis 2002, 34(10):1379-1385.
31. Arya B., Hussian S., Hariharan S. Rhodococcus equi pneumonia in a renal transplant patient: a case report and review of literature. Clin Transplant 2004, 18(6):748-752.
32. Tse K.C., Tang S.C., Chan T.M., et al. Rhodococcus lung abscess complicating kidney transplantation: successful management by combination antibiotic therapy. Transpl Infect Dis 2008, 10(1):44-47.
33. Sabater L., Andreu H., Garcia-Valdecasas J.C., et al. Rhodococcus equi infection after liver transplantation. Transplantation 1996, 61(6):980-982.
34. Simsir A., Oldach D., Forest G., et al. Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: diagnosis by fine-needle aspiration biopsy. Diagn Cytopathol 2001, 24(2):129-131.
35. La Rocca E., Gesu G., Caldara R., et al. Pulmonary infection caused by Rhodococcus equi in a kidney and pancreas transplant recipient: a case report. Transplantation 1998, 65(11):1524-1525.
36. Lo A., Stratta R.J., Trofe J., et al. Rhodococcus equi pulmonary infection in a pancreas-alone transplant recipient: consequence of intense immunosuppression. Transpl Infect Dis 2002, 4(1):46-51.
37. Schilz R.J., Kavuru M.S., Hall G., et al. Spontaneous resolution of rhodococcal pulmonary infection in a liver transplant recipient. South Med J 1997, 90(8):851-854.
38. Stiles B.M., Isaacs R.B., Daniel T.M., et al. Role of surgery in Rhodococcus equi pulmonary infections. J Infect 2002, 45(1):59-61.
39. Munoz P., Burillo A., Palomo J., et al. Rhodococcus equi infection in transplant recipients: case report and review of the literature. Transplantation 1998, 65(3):449-453.
40. Singh N., Paterson D.L. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005, 18(1):44-69.
41. Richardson M., Lass-Florl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 2008, 14(Suppl 4):5-24.
42. Hachem R.Y., Kontoyiannis D.P., Boktour M.R., et al. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer 2004, 101(7):1594-1600.
43. Iwen P.C., Rupp M.E., Langnas A.N., et al. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis 1998, 26(5):1092-1097.
44. Steinbach W.J., Benjamin D.K., Kontoyiannis D.P., et al. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 2004, 39(2):192-198.
45. Steinbach W.J., Perfect J.R., Schell W.A., et al. In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. Antimicrob Agents Chemother 2004, 48(9):3217-3225.
46. Tokimatsu I., Kushima H., Iwata A., et al. Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in vitro susceptibility of A. terreus isolate to micafungin. Intern Med 2007, 46(11):775-779.
47. Walsh T.J., Petraitis V., Petraitiene R., et al. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J Infect Dis 2003, 188(2):305-319.
48. Perfect J.R., Marr K.A., Walsh T.J., et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003, 36(9):1122-1131.
49. Lass-Florl C., Griff K., Mayr A., et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 2005, 131(2):201-207.
50. Caston J.J., Linares M.J., Gallego C., et al. Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi. Chest 2007, 131(1):230-236.
51. Panackal A.A., Imhof A., Hanley E.W., et al. Aspergillus ustus infections among transplant recipients. Emerg Infect Dis 2006, 12(3):403-408.
52. Cooke F.J., Terpos E., Boyle J., et al. Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin. Clin Microbiol Infect 2003, 9(12):1238-1241.
53. Stiller M.J., Teperman L., Rosenthal S.A., et al. Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient. J Am Acad Dermatol 1994, 31(2 Pt 2):344-347.
54. Pavie J., Lacroix C., Hermoso D.G., et al. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. J Clin Microbiol 2005, 43(9):4902-4904.
55. Baddley J.W., Stroud T.P., Salzman D., et al. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001, 32(9):1319-1324.
56. Nakai K., Kanda Y., Mineishi S., et al. Primary cutaneous aspergillosis caused by Aspergillus ustus following reduced-intensity stem cell transplantation. Ann Hematol 2002, 81(10):593-596.
57. Azzola A., Passweg J.R., Habicht J.M., et al. Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection. J Clin Microbiol 2004, 42(10):4805-4808.
58. Verweij P.E., van den Bergh M.F., Rath P.M., et al. Invasive aspergillosis caused by Aspergillus ustus: case report and review. J Clin Microbiol 1999, 37(5):1606-1609.
59. Iwen P.C., Rupp M.E., Bishop M.R., et al. Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation. J Clin Microbiol 1998, 36(12):3713-3717.
60. Bretagne S., Marmorat-Khuong A., Kuentz M., et al. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997, 35(1):7-15.
61. Vagefi P.A., Cosimi A.B., Ginns L.C., et al. Cutaneous Aspergillus ustus in a lung transplant recipient: emergence of a new opportunistic fungal pathogen. J Heart Lung Transplant 2008, 27(1):131-134.
62. Olorunnipa O., Zhang A.Y., Curtin C.M. Invasive aspergillosis of the hand caused by Aspergillus ustus: a case report. Hand (N Y) 2010, (5):102-105.
63. Florescu D.F., Iwen P.C., Hill L.A., et al. Cerebral aspergillosis caused by Aspergillus ustus following orthotopic heart transplantation: case report and review of the literature. Clin Transplant 2009, 23(1):116-120.
64. Goldberg S.L., Geha D.J., Marshall W.F., et al. Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole. Clin Infect Dis 1993, 16(6):803-805.
65. Merz W.G., Karp J.E., Hoagland M., et al. Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis 1988, 158(5):1046-1055.
66. Gupta A.K., Baran R., Summerbell R.C. Fusarium infections of the skin. Curr Opin Infect Dis 2000, 13(2):121-128.
67. Nucci M., Marr K.A., Queiroz-Telles F., et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004, 38(9):1237-1242.
68. Sampathkumar P., Paya C.V. Fusarium infection after solid-organ transplantation. Clin Infect Dis 2001, 32(8):1237-1240.
69. Arney K.L., Tiernan R., Judson M.A. Primary pulmonary involvement of Fusarium solani in a lung transplant recipient. Chest 1997, 112(4):1128-1130.
70. Guinvarc'h A., Guilbert L., Marmorat-Khuong A., et al. Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient. Mycoses 1998, 41(1-2):59-61.
71. Pfaller M.A., Marco F., Messer S.A., et al. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis 1998, 30(4):251-255.
72. Nucci M., Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007, 20(4):695-704.
73. Raad, Hachem R.Y., Herbrecht R., et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 2006, 42(10):1398-1403.
74. Castiglioni B., Sutton D.A., Rinaldi M.G., et al. Pseudallescheria boydii (anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) 2002, 81(5):333-348.
75. Cimon B., Carrere J., Vinatier J.F., et al. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000, 19(1):53-56.
76. Cooley L., Spelman D., Thursky K., et al. Infection with Scedosporium apiospermum and S. prolificans, Australia. Emerg Infect Dis 2007, 13(8):1170-1177.
77. Husain S., Munoz P., Forrest G., et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005, 40(1):89-99.
78. Tadros T.S., Workowski K.A., Siegel R.J., et al. Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis. Hum Pathol 1998, 29(11):1266-1272.
79. Panackal A.A., Marr K.A. Scedosporium/Pseudallescheria infections. Semin Respir Crit Care Med 2004, 25(2):171-181.
80. Raj R., Frost A.E. Scedosporium apiospermum fungemia in a lung transplant recipient. Chest 2002, 121(5):1714-1716.
81. Troke P., Aguirrebengoa K., Arteaga C., et al. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother 2008, 52(5):1743-1750.
82. Sahi H., Avery R.K., Minai O.A., et al. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant 2007, 26(4):350-356.
83. Rodriguez-Tudela J.L., Berenguer J., Guarro J., et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol 2009, 47(4):359-370.
84. Tamm M., Malouf M., Glanville A. Pulmonary scedosporium infection following lung transplantation. Transpl Infect Dis 2001, 3(4):189-194.
85. Meletiadis J., Mouton J.W., Meis J.F., et al. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003, 47(1):106-117.
86. Rogasi P.G., Zanazzi M., Nocentini J., et al. Disseminated Scedosporium apiospermum infection in renal transplant recipient: long-term successful treatment with voriconazole: a case report. Transplant Proc 2007, 39(6):2033-2035.
87. Falsey A.R. Human metapneumovirus infection in adults. Pediatr Infect Dis J 2008, 27(10 Suppl):S80-S83.
88. Raza K., Ismailjee S.B., Crespo M., et al. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant 2007, 26(8):862-864.
89. Dare R., Sanghavi S., Bullotta A., et al. Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis. J Clin Microbiol 2007, 45(2):548-552.
90. Hopkins P., McNeil K., Kermeen F., et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 2008, 178(8):876-881.
91. van den Hoogen B.G., de Jong J.C., Groen J., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001, 7(6):719-724.
92. Williams J.V., Martino R., Rabella N., et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 2005, 192(6):1061-1065.
93. Cane P.A., van den Hoogen B.G., Chakrabarti S., et al. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant 2003, 31(4):309-310.
94. Evashuk K.M., Forgie S.E., Gilmour S., et al. Respiratory failure associated with human metapneumovirus infection in an infant posthepatic transplant. Am J Transplant 2008, 8(7):1567-1569.
95. Gerna G., Vitulo P., Rovida F., et al. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J Med Virol 2006, 78(3):408-416.
96. Larcher C., Geltner C., Fischer H., et al. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant 2005, 24(11):1891-1901.
97. Oliveira R., Machado A., Tateno A., et al. Frequency of human metapneumovirus infection in hematopoietic SCT recipients during 3 consecutive years. Bone Marrow Transplant 2008, 42(4):265-269.
98. Debiaggi M., Canducci F., Terulla C., et al. Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. New Microbiol 2007, 30(3):255-258.
99. Kamble R.T., Bollard C., Demmler G., et al. Human metapneumovirus infection in a hematopoietic transplant recipient. Bone Marrow Transplant 2007, 40(7):699-700.
100. Huck B., Egger M., Bertz H., et al. Human metapneumovirus infection in a hematopoietic stem cell transplant recipient with relapsed multiple myeloma and rapidly progressing lung cancer. J Clin Microbiol 2006, 44(6):2300-2303.
101. Englund J.A., Boeckh M., Kuypers J., et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 2006, 144(5):344-349.
102. Centers for Disease Control and Prevention (CDC) Brief report: Lymphocytic choriomeningitis virus transmitted through solid organ transplantation-Massachusetts, 2008. MMWR Morb Mortal Wkly Rep 2008, 57(29):799-801.
103. Fischer S.A., Graham M.B., Kuehnert M.J., et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006, 354(21):2235-2249.
104. Palacios G., Druce J., Du L., et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008, 358(10):991-998.
105. Kumar D., Tellier R., Draker R., et al. Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant 2003, 3(8):977-981.
106. Lam M.F., Ooi G.C., Lam B., et al. An indolent case of severe acute respiratory syndrome. Am J Respir Crit Care Med 2004, 169(1):125-128.